Meidani Mohsen, Khorvash Farzin, Abbasi Saeed, Cheshmavar Masoumeh, Tavakoli Hossein
Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Prev Med. 2018 Oct 12;9:93. doi: 10.4103/ijpvm.IJPVM_370_17. eCollection 2018.
Pneumonia is one of the most common hospital-acquired infections among bedridden patients in Intensive Care Units (ICUs). Colonization of mouth and pharynx by pathogenic bacteria and their aspiration into the lower respiratory tract is an important step in pathogenesis of hospital-acquired pneumonia. The purpose of this study was to compare the effects of chlorhexidine and potassium permanganate mouthwashes in preventing incidence of hospital-acquired pneumonia in hospitalized patients in the ICU.
This study is a clinical trial, conducted on 150 patients on ventilator in ICU. Patients were divided into three groups: Chlorhexidine group, potassium permanganate group, and control group. Mouthwashing three times a day, each time 5 min for 1 week by sterile gas with 10 cc solution of chlorhexidine, potassium permanganate, or placebo, was performed. Finally, pneumonia incidence was recorded, according to the Center for Disease Control and Prevention criteria. The data were analyzed by SPSS software version 20.
In the present study, 28 cases of pneumonia among 150 patients on ventilator were investigated. There were 15 (30%), 6 (12%), and 7 (14%) incidences of pneumonia in control, chlorhexidine, and permanganate group, respectively. Pneumonia incidence in these groups differed significantly ( = 0.041).
The use of common mouthwashes, especially chlorhexidine solution, for washing oropharynx of ICU patients, can decrease pneumonia incidence, especially in patients under ventilation. Thus, washing and sterilizing mouth of patients with mouthwashes is recommended due to the high risk of hospital-acquired pneumonia in these patients.
肺炎是重症监护病房(ICU)卧床患者中最常见的医院获得性感染之一。病原菌在口腔和咽部定植并吸入下呼吸道是医院获得性肺炎发病机制中的重要一步。本研究的目的是比较洗必泰和高锰酸钾漱口液在预防ICU住院患者医院获得性肺炎发生率方面的效果。
本研究是一项临床试验,对150例ICU中使用呼吸机的患者进行。患者分为三组:洗必泰组、高锰酸钾组和对照组。用含10毫升洗必泰溶液、高锰酸钾溶液或安慰剂的无菌气体每天漱口三次,每次5分钟,持续1周。最后,根据疾病控制与预防中心的标准记录肺炎发生率。数据用SPSS 20版软件进行分析。
在本研究中,对150例使用呼吸机的患者中的28例肺炎病例进行了调查。对照组、洗必泰组和高锰酸钾组的肺炎发生率分别为15例(30%)、6例(12%)和7例(14%)。这些组的肺炎发生率有显著差异(P = 0.041)。
使用普通漱口液,尤其是洗必泰溶液,对ICU患者进行口咽冲洗,可降低肺炎发生率,尤其是在通气患者中。因此,鉴于这些患者发生医院获得性肺炎的风险较高,建议用漱口液对患者口腔进行冲洗和消毒。